Optimization of gefitinib analogues with potent anticancer activity

Bioorganic & Medicinal Chemistry Letters
2014.0

Abstract

The interactions of gefitinib (Iressa) in EGFR are hydrogen bonding and van der Waals forces through quinazoline and aniline rings. However the morpholino group of gefitinib is poorly ordered due to its weak electron density. A series of novel piperazino analogues of gefitinib where morpholino group substituted with various piperazino groups were designed and synthesized. Most of them indicated significant anti-cancer activities against human cancer cell lines. In particular, compounds 52-54 showed excellent potency against cancer cells. Convergent synthetic approach has been developed for the synthesis of gefitinib intermediate which can lead to gefitinib as well as numerous analogues.

Knowledge Graph

Similar Paper

Optimization of gefitinib analogues with potent anticancer activity
Bioorganic & Medicinal Chemistry Letters 2014.0
Combination of 4-anilinoquinazoline, arylurea and tertiary amine moiety to discover novel anticancer agents
Bioorganic & Medicinal Chemistry 2016.0
Synthesis and biological evaluation of novel tricyclic oxazine and oxazepine fused quinazolines. Part 2: Gefitinib analogs
Bioorganic & Medicinal Chemistry Letters 2016.0
Design and synthesis of novel Gefitinib analogues with improved anti-tumor activity
Bioorganic & Medicinal Chemistry 2010.0
Synthesis and in vitro antitumor activities of novel 4-anilinoquinazoline derivatives
European Journal of Medicinal Chemistry 2009.0
Facile and efficient synthesis and biological evaluation of 4-anilinoquinazoline derivatives as EGFR inhibitors
Bioorganic & Medicinal Chemistry Letters 2016.0
Novel 4-anilinoquinazoline derivatives featuring an 1-adamantyl moiety as potent EGFR inhibitors with enhanced activity against NSCLC cell lines
European Journal of Medicinal Chemistry 2016.0
Novel 5-substituted-2-anilinoquinolines with 3-(morpholino or 4-methylpiperazin-1-yl)propoxy moiety as broad spectrum antiproliferative agents: Synthesis, cell based assays and kinase screening
Bioorganic & Medicinal Chemistry Letters 2016.0
Synthesis and biological evaluation of novel tricyclic oxazine and oxazepine fused quinazolines. Part 1: Erlotinib analogs
Bioorganic & Medicinal Chemistry Letters 2014.0
Four-membered heterocycles-containing 4-anilino-quinazoline derivatives as epidermal growth factor receptor (EGFR) kinase inhibitors
Bioorganic & Medicinal Chemistry Letters 2013.0